PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines

International Journal of Cancer

Volumn 91, Issue 2, 2001, Pages 219-224

  Kondo, Kei Ichi ^a   Yao, Masahiro ^a   Kobayashi, Kazuki ^a   Ota, Shinsuke ^b   Yoshida, Minoru ^a   Kaneko, Shigeki ^a   Baba, Masaya ^a   Sakai, Naoki ^b   Kishida, Takeshi ^a   Kawakami, Satoshi ^a   Uemura, Hiroji ^a   Nagashima, Yoji ^a   Nakatani, Yukio ^b   Hosaka, Masahiko ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Carcinoma; Cell line; Mutation; PTEN MMAC1 TEP1 gene; Renal cell; Tumor suppressor

Indexed keywords

DNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTICLE; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CELL LINE; CHROMOSOME MUTATION; CONTROLLED STUDY; COWDEN SYNDROME; DNA SEQUENCE; GENE DELETION; GENE INSERTION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MUTATION; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 17744399699     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1034>3.0.CO;2-S     Document Type: Article

References (40)

1. Lessons from hereditary colorectal cancer
2. Mutations of the VHL tumour suppressor gene in renal carcinoma
3. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas
4. Allelotype of renal cell carcinoma
5. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma
6. Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes
7. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
8. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
9. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta
10. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma
11. PTEN gene mutations are seen in high-grade but not in low-grade gliomas
12. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer
13. PTEN1 is frequently mutated in primary endometrial carcinomas
14. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
15. Germline mutations in PTEN are present in Bannayan-Zonana syndrome
16. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
17. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
18. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer
19. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: Differential involvement of focal adhesion kinase and p130Cas
20. Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma
21. Lack of deletions of the PTEN/MMAC1 and MXI1 loci in renal cell carcinoma by interphase cytogenetics
22. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
23. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines
24. A comprehensive genetic map of the human genome based on 5,264 microsatellites
25. Somatic mutations of PTEN in glioblastoma multiforme
26. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences
27. Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis
28. Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers
29. Antioncogenes and human cancer 1993
30. Differential expression of MMAC/PTEN in glioblastoma multiforme: Relationship to localization and prognosis
31. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN
32. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
33. Overexpression of c-met proto-oncogene associated with chromophilic renal cell carcinoma with papillary growth
34. Molecular cytogenetic analysis of 17 renal cancer cell lines: Increased copy number at 5q31-33 in cell lines from nonpapillary carcinomas
35. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies
36. Microsatellite instability occurs infrequently in sporadic renal cell carcinoma
37. Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary
38. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers